CellSource Co (TSE:4880) Total Stockholders Equity : 円5,961 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Total Stockholders Equity?

CellSource Co's Total Stockholders Equity for the quarter that ended in Jan. 2024 was 円5,961 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. CellSource Co's Book Value per Share for the quarter that ended in Jan. 2024 was 円300.97. The ratio of a company's debt over equity can be used to measure how leveraged this company is. CellSource Co's Debt-to-Equity for the quarter that ended in Jan. 2024 was 0.00.

CellSource Co Total Stockholders Equity Historical Data

The historical data trend for CellSource Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Total Stockholders Equity Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Stockholders Equity

Get a 7-Day Free Trial

1,607.70

2,042.51

2,720.35

3,785.53

6,202.00

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Stockholders Equity	Get a 7-Day Free Trial															4,005.84	4,201.64	4,487.18	6,202.00	5,960.95

CellSource Co (TSE:4880) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

CellSource Co's Book Value per Share for the quarter that ended in Jan. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(5960.953	-	0)	/	19.8055
	=	300.97

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

CellSource Co's Debt-to-Equity for the quarter that ended in Jan. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	5960.953
	=	0.00

CellSource Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CellSource Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines